By G HossainPosted on June 11, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. Kardigan stitches up $369M IPO plan Post navigation SonoThera bags $125M series B to advance safer gene therapiesSky-high Parabilis, Kailera IPOs spur optimism—but only for derisked biotechs